Company The IBN SINA Pharmaceutical Industry PLC

Equities

IBNSINA

BD0464IBNSN2

Pharmaceuticals

End-of-day quote Dhaka S.E. 06:00:00 2024-04-24 pm EDT 5-day change 1st Jan Change
253.7 BDT +0.28% Intraday chart for The IBN SINA Pharmaceutical Industry PLC -2.08% -11.48%

Business Summary

The IBN SINA Pharmaceutical Industry Ltd is a pharmaceutical company in Bangladesh. The Company is engaged in the production of pharmaceutical drugs and natural medicines. It sells its products to both local and international market. The Company offers its products in a range of therapeutic areas, such as anti-allergic occular, anti-arthritis supplement, anti-asthmatic, anti-emetic, antifungal, anti-glucoma, anti-histamine, anti-malarial, anti-protozoal, antibiotic, antivertigo agent, antiviral, cough expectorant, dry eye syndrome, hormone products, nasal decongestant, topical, urinary incontinence and sterois-occular. The Company offers its products under various brand names, such as Aceril, Acipam, Algirex, Azopt, Antigrain, Bactin, Betasil, Buscon, Bromofen, Camide, Cardil, Cloram-D, Cinarzin, Dermacort, Dexon, Donadin, Emiston, Eylon, Fexomin, Fungin, Fruson, Gatsina, Glamor, Hexyclore, Iluca, Inseac, Ketof, Lansina, Lytex, Malex, Metsina, Natazol and Neuralgin.

Number of employees: 4,000

Sales per Business

BDT in Million2022Weight2023Weight Delta
Tablet
35.6 %
3,213 37.9 % 3,248 35.6 % +1.07%
Liquid Bottles
22.4 %
2,037 24.0 % 2,041 22.4 % +0.20%
Capsule
22.2 %
1,742 20.5 % 2,023 22.2 % +16.13%
Injection
7.7 %
564 6.6 % 704 7.7 % +24.93%
Drops
5.5 %
393 4.6 % 499 5.5 % +26.86%
Dry Syrup/ORS
4.5 %
365 4.3 % 409 4.5 % +12.17%
Ointment
2.2 %
166 2.0 % 201 2.2 % +21.43%

Sales per region

BDT in Million2022Weight2023Weight Delta
Bangladesh
100.0 %
8,480 100.0 % 9,125 100.0 % +7.61%

Managers

Managers TitleAgeSince
Chief Executive Officer 69 02-12-31
Director of Finance/CFO 70 12-12-31
Director of Finance/CFO - -
Compliance Officer - -
Director/Board Member 76 82-12-31
Investor Relations Contact - -
Corporate Secretary - -

Members of the board

Members of the board TitleAgeSince
Director/Board Member 76 82-12-31
Director/Board Member 64 22-01-15
Chief Executive Officer 69 02-12-31
Director/Board Member 69 -
Director of Finance/CFO 70 12-12-31
Compliance Officer - -
Chairman 74 15-12-31
Director/Board Member 70 -
Director/Board Member 67 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 31,243,627 14,822,477 ( 47.44 %) 0 47.44 %

Company contact information

The IBN SINA Pharmaceutical Industry Plc

Tanin Center 3 Asad Gate

1207, Dhaka

+

http://www.ibnsinapharma.com
address The IBN SINA Pharmaceutical Industry PLC(IBNSINA)

Sales per Business

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
253 BDT
Average target price
370 BDT
Spread / Average Target
+46.25%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. IBNSINA Stock
  4. Company The IBN SINA Pharmaceutical Industry PLC